VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER
申请人:Haick Hossam
公开号:US20130143247A1
公开(公告)日:2013-06-06
The present invention provides methods of identifying a genetic abnormality such as mutation in EGFR or KRAS or ALK which is associated with the management of lung cancer or diagnosing, prognosing or monitoring the treatment of pre-cancerous conditions of the lung, such as bronchial dysplasia or atypical alveolar hyperplasia (AAH), through the detection of at least one volatile organic compound indicative of these states.
US9315848B2
申请人:——
公开号:US9315848B2
公开(公告)日:2016-04-19
[EN] VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER<br/>[FR] COMPOSÉS ORGANIQUES VOLATILS POUR LA DÉTECTION D'UNE DYSPLASIE CELLULAIRE ET DE MODIFICATIONS GÉNÉTIQUES ASSOCIÉES AU CANCER DU POUMON
申请人:TECHNION RES & DEV FOUNDATION
公开号:WO2012023138A2
公开(公告)日:2012-02-23
The present invention provides methods of identifying a genetic abnormality such as mutation in EGFR or KRAS or ALK which is associated with the management of lung cancer or diagnosing, prognosing or monitoring the treatment of pre-cancerous conditions of the lung, such as bronchial dysplasia or atypical alveolar hyperplasia (AAH), through the detection of at least one volatile organic compound indicative of these states.